Psoriasis - Revision history

Natalie.Murray@anthonynolan.org: /* Version */

2026-10-14T08:51:23Z

Version

2026-10-14T08:50:52Z

Acceptability at Recruitment

2026-10-14T08:50:24Z

Acceptability at CT / Work-Up

2026-10-13T14:28:38Z

Acceptability at Recruitment

← Older revision		Revision as of 14:28, 13 October 2026
Line 1:		Line 1:
	==Acceptability at Recruitment==		==Acceptability at Recruitment==
	~~QUALIFIED~~		ACCEPTABLE except when associated with psoriatic arthritis

			Psoriatic arthritis
			NOT ACCEPTTABLE

	==Acceptability at CT / Work-Up==		==Acceptability at CT / Work-Up==

2025-09-15T10:32:43Z

Guidance at VT

← Older revision		Revision as of 10:32, 15 September 2025
Line 27:		Line 27:
	Mild and moderate cases, treated with topical therapy (tar, creams etc...) or a single course of UV therapy (PUVA) are acceptable for BM only and may be acceptable for PBSC on a case-by-case basis and following discussion with donor regarding possibility of exacerbation.		Mild and moderate cases, treated with topical therapy (tar, creams etc...) or a single course of UV therapy (PUVA) are acceptable for BM only and may be acceptable for PBSC on a case-by-case basis and following discussion with donor regarding possibility of exacerbation.

	~~Retinoic~~ acid derivatives ~~such as~~ acitretin ~~are acceptable~~, ~~as long as~~ the ~~appropriate time period has passed since their administration and donation. See [[Retinoic Acid Derivatives]]~~.
			Use of retinoic acid derivatives:

			Unacceptable if ever taken Etretinate (Tigason).

			Acceptable: Donors having taken, or currently taking, acitretin (Neotigason) or Isotretinoin (Roaccutane) may join the register.
			*At VT/Work up, must inform transplant centre if a donor is taking any of these medications, or has done so at any point in the last 12 months.

	==Pseudonyms or Related Conditions==		==Pseudonyms or Related Conditions==

2025-07-24T16:11:19Z

Guidance

2025-07-24T16:11:04Z

Version

2025-07-24T16:10:32Z

Guidance

← Older revision		Revision as of 16:10, 24 July 2025
Line 16:		Line 16:

	==Guidance==		==Guidance==

			=== Guidance at registration ===

			Acceptable


			=== Guidance at VT ===

	Unacceptable if severe or widespread, or has ever suffered from psoriatic arthritis (joint involvement). Unacceptable if has received more than one course (up to three months) of UV treatment. Unacceptable if less than 1 year since completing course of systemic immunosuppression.		Unacceptable if severe or widespread, or has ever suffered from psoriatic arthritis (joint involvement). Unacceptable if has received more than one course (up to three months) of UV treatment. Unacceptable if less than 1 year since completing course of systemic immunosuppression.

2016-09-07T16:00:36Z

Version

2016-09-07T16:00:23Z

Guidance

← Older revision		Revision as of 16:00, 7 September 2016
Line 18:		Line 18:
	Unacceptable if severe or widespread, or has ever suffered from psoriatic arthritis (joint involvement). Unacceptable if has received more than one course (up to three months) of UV treatment. Unacceptable if less than 1 year since completing course of systemic immunosuppression.		Unacceptable if severe or widespread, or has ever suffered from psoriatic arthritis (joint involvement). Unacceptable if has received more than one course (up to three months) of UV treatment. Unacceptable if less than 1 year since completing course of systemic immunosuppression.

	Mild and moderate cases, treated with topical therapy (tar, creams etc...) or a single course of UV therapy (PUVA) are acceptable for BM only.		Mild and moderate cases, treated with topical therapy (tar, creams etc...) or a single course of UV therapy (PUVA) are acceptable for BM only and may be acceptable for PBSC on a case-by-case basis and following discussion with donor regarding possibility of exacerbation.

	Retinoic acid derivatives such as acitretin are acceptable, as long as the appropriate time period has passed since their administration and donation. See [[Retinoic Acid Derivatives]].		Retinoic acid derivatives such as acitretin are acceptable, as long as the appropriate time period has passed since their administration and donation. See [[Retinoic Acid Derivatives]].